What is MAZE's cash & equivalents?

MAZE (MAZE) reported cash & equivalents of $198.77M in Q1 2026.

How has MAZE's cash & equivalents changed year-over-year?

MAZE's cash & equivalents decreased by 32.5% year-over-year, from $294.37M to $198.77M.

What does cash & equivalents mean?

Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

MAZE MAZE Cash & Equivalents

Cash & Equivalents at other companies

Vertex PharmaceuticalsVRTX

$5.5B+17.5%

Septerna, Inc.SEPN

$71.61M-65.9%

Stoke Therapeutics, Inc.STOK

$155.66M-43.4%

Olema Pharmaceuticals, Inc.OLMA

$52.55M+3.8%

ZymeworksZYME

$244.28M+221%

Nurix Therapeutics, Inc.NRIX

$72.16M-6.1%

Other financials

Income statement

See full

Revenue$20.0M—

Operating income-$26.6M+25.0%

Net income-$24.2M+26.2%

EPS (diluted)-$0.45+60.9%

Balance sheet

See full

Total debt$61.2M+137%

Total equity$341.7M+17.0%

Total assets$419.7M+26.1%

Cash flow

See full

Operating cash flow-$39.1M-32.5%

CapEx$93.0K-68.9%

Free cash flow-$39.2M-31.5%

Valuation

See full

Market cap$1.48B—

Enterprise value$1.34B—

P/S7.9×—

Profitability

See full

Operating margin-71.5%—

Net margin-65.4%—

FCF margin-65.1%—

Returns & leverage

See full

Return on equity-38.7%—

Debt / equity0.2×+0.1×

Current ratio17.9×+1.8×

Where this comes from

Reported directly by MAZE in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The official record: MAZE’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about MAZE's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MAZE's cash & equivalents?: MAZE (MAZE) reported cash & equivalents of $198.77M in Q1 2026.
How has MAZE's cash & equivalents changed year-over-year?: MAZE's cash & equivalents decreased by 32.5% year-over-year, from $294.37M to $198.77M.
What does cash & equivalents mean?: Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.